News and Announcements
Second National Institutes of Health Grant to 4Dx
- Published June 22, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
A second major USA hospital has received a grant award of US $600,000 from the United States National Institutes of Health for the purchase of a 4Dx preclinical lung scanner. Scheduled for delivery later this year, the second scanner will greatly increase the profile of 4Dx and showcase how 4Dx technology will assist in the diagnosis, monitoring and treatment of asthma.
About 4Dx
4Dx brings a technological solution set to disrupt this multi-billion dollar sector through compelling unique competitive advantages over existing respiratory diagnostics. The respiratory diagnostic sector represents a global market of over $25B per annum. Currently served by out of date technology, 4Dx has enormous scope for financial success as well as life-changing advancement for medicine. Offering more detailed information, faster validation of treatment efficacy, lower costs, and reduced radiation dosage, 4Dx allows for earlier detection of disease and earlier intervention. The ability to identify lung diseases earlier is creating a critical shift in the practice model from cure to prevention.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
